Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control

NCT02571608 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study halted prematurely, prior to enrollment of first participant

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

McMaster University